The combined group will focus on delivering innovative cancer diagnostics to address unmet needs in early cancer detection.

Biotech companies in $24m merger

South Perth-based Bard1 Life Sciences is forming a new cancer diagnostic business with a fellow listed medtech company in Victoria.


(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 29/05/20

1 year TSR5 year TSR
30thPYC Therapeutics249%30%
165thBARD1 Life Sciences56%6%
497thDigital Wine Ventures-17%-15%
541st4DS Memory-23%5%
671 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

$12k Bought
$0 Bought
$10k Issued
Total value as at the date of the transaction
Powered by Morningstar ®


153rd↑BARD1 Life Sciences$571k
179th↑Digital Wine Ventures$39k
180th↑4DS Memory$39k
186th↓PYC Therapeutics$250
197 listed industrial companies ranked by revenue.
Powered by Morningstar ®